| Detailed information |
|---|
| CancerLivER ID | 2317 |
| Biomarker | NDRG2 |
| Biomarker Name/Symbol (given in Publication) | NDRG2 |
| Biomolecule | Protein and RNAs |
| Subject | Human |
| Degree of Validity | Potential biomarker for HCC prognosis and diagnosis; NDRG2 might be a novel candidate suppressor of tumor metastasis in HCC; but not validated on independent dataset |
| Experimental Condition | HCC v/s cirrhosis/healthy/non-tumor HCC; associated with recurrence and tumor grade |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Downregulated in HCC than non-tumor |
| Level of significance | p < 0.05 |
| Source | Tissue |
| PMID | 18519680 |
| Type of Biomarker | Diagnostic and Prognostic |
| Pathway | dendritic cell and neuron differentiation |
| Cohort | 57 tumor and 41 nontumor liver tissues of HCC patients; iver cancer cell lines, PLC/PRF/5 and SK-Hep-1, |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | HCC v/s non-tumor HCC |
| Year of Publication | 2008 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |